Evaluation of Antiangiogenic Potential of Ethanolic Extract of Bauhinia variegata Leaves in Mice
DOI:
https://doi.org/10.48165/ijvsbt.19.5.14Keywords:
Angiogenesis, Bauhinia variegata, VEGF, MVD, Sponge implantAbstract
The present study was planned to evaluate the antiangiogenic potential of ethanolic extract of Bauhinia variegata using the sponge implantation method in mice. Swiss albino adult male mice (n=30) weighing 18-22 g were divided into three groups comprising of ten animals in each. Groups I, II, and III were used as negative control, positive (SU5416) control, and treatment (extract of Bauhinia variegata) groups, respectively. Sponges were implanted subcutaneously and the mice were sacrificed after 14th day. The implanted sponges were then segregated and processed for haemoglobin concentration, vascular endothelial growth factor (VEGF) estimation, and histopathological evaluation. In treatment groups I to III, the mean (±SE) haemoglobin content was found to be 1.919±0.048, 0.410±0.049, and 1.604±0.101 µg/mg weight of sponge, VEGF values 2.462±0.181, 0.529±0.044, and 1.609±0.069 pg/mg weight of sponge, and the mean vessels density (±SE) per field (microscopically under 40x) was 14.9±1.25, 1.3±0.3, and 10.6±0.92, respectively. The extract of Bauhinia variegata was found to have inhibitory potential on hemoglobin concentration, VEGF concentration, and mean vascular density.
Downloads
References
Agrawal, R.C., & Pandey, S. (2009). Evaluation of the anticarcinogenic and antimutagenic potential of Bauhinia variegata extract in Swiss albino mice. Asian Pacific Journal of Cancer Prevention, 10(5), 913-916.
Bairagi, S.M., Aher, A.A., & Nimase, P.K. (2012). In vitro anthelmintic activity of Bauhinia variegata bark (Leguminosae). International Journal of Pharmacy and Pharmaceutical Sciences, 4(3), 672-674.
Gautam, S. (2012). Bauhinia variegata Linn: All-purpose utility and medicinal tree. Forestry Bulletin, 12(2), 61-64.
Gosavi, S.C., Karande, V.V., Ghumare, B C., Mote, C.S., Mhase, P.P., & Mehere, P.V. (2019). Evaluation of the antiangiogenic activity of Nigella sativa extract by sponge implantation method in a mouse model. Indian Journal of Pure and Applied Biosciences, 7(5), 25-29.
Gurjar, H., Pandey, H., Verma, A., Irchhaiya, R., & Singh, P.P. (2018). Antidiabetic activity of Bauhinia variegata extracts in alloxan-induced diabetic rats. Journal of Drug Delivery and Therapeutics, 8(1), 29-32.
Hoff, P.M., & Machado, K.K. (2012). Role of angiogenesis in the pathogenesis of cancer. Cancer Treatment Reviews, 38(7), 825-833.
Kieran, M.W., Supko, J.G., Wallace, D., Fruscio, R., Poussaint, T.Y., Phillips, P., & Pediatric Brain Tumor Consortium. (2009). Phase I study of SU5416, a small molecule inhibitor of the vascular endothelial growth factor receptor (VEGFR) in refractory pediatric central nervous system tumors. Pediatric Blood & Cancer, 52(2), 169-176.
Kolhe, R., Acharya, R.N. and Ravishankar, B. (2015). Chronic toxicity study of stem bark powder of Kanchanara (Bauhinia variegata L.) in albino rats. Indian Journal of Natural Products and Resources, 5(3), 244-248.
Kolte, D., McClung, J.A., & Aronow, W.S. (2016). Vasculogenesis and angiogenesis. In: Translational Research in Coronary Artery Disease. Academic Press, pp. 49-65.
McCarty, M.F., Cheryl, H., Corazon, B., Bucana, D., & Fidler, I.J. (2002). Quantitative and qualitative in vivo angiogenesis assay. International Journal of Oncology 21, 5-10.
Mishra, A., Sharma, A.K., Kumar, S., Saxena, A.K., & Pandey, A.K. (2013). Bauhinia variegata leaf extracts exhibit considerable antibacterial, antioxidant, and anticancer activities. BioMed Research International, 2013.
Mohamed, M.A., Mammoud, M.R., & Hayen, H. (2009). Evaluation of antinociceptive and anti-inflammatory activities of a new triterpene saponin from Bauhinia variegata leaves. Zeitschrift für Naturforschung C, 64(11-12), 798-808.
Nishida, N., Yano, H., Nishida, T., Kamura, T., & Kojiro, M. (2006). Angiogenesis in cancer. Vascular Health and Risk Management, 2(3), 213.
Pandey, S. (2017). In vivo antitumor potential of extracts from different parts of Bauhinia variegata Linn. Against b16f10 melanoma tumor model in c57bl/6 mice. Applied Cancer Research, 37(1), 1-14.
Pani, S.R., Mishra, S., Sahoo, S., & Panda, P.K. (2011). Nephroprotective effect of Bauhinia variegata (Linn.) whole stem extract against cisplatin-induced nephropathy in rats. Indian Journal of Pharmacology, 43(2), 200.
Rajkapoor, B., Jayakar, B., & Murugesh, N. (2003). Antitumour activity of Bauhinia variegata on Dalton’s ascitic lymphoma. Journal of Ethnopharmacology, 89(1), 107-109.
Rathod, R.V., Karande, V.V., Ghumare, B.C., Rangnekar, M., Mote, C.S., Lonkar, V.D., & Tulavi, S.M. (2022). Evaluation of the antiangiogenic activity of Justicia adhatoda extract by sponge implantation method in mouse. Journal of Veterinary Pharmacology and Toxicology, 21(1), 9-11.
Singh, M., & Kale, R.K. (2010). Abstract A64: Chemopreventive potential of Bauhinia variegata against DMBA-induced skin papilloma genesis in Swiss albino mice. Cancer Prevention Research, 3(1_Supplement), A64-A64.
Sun, Q., Heilmann, J., & König, B. (2015). Natural phenolic metabolites with antiangiogenic properties – A review from the chemical point of view. Beilstein Journal of Organic Chemistry, 11(1), 249-264.
Yadav, L., Puri, N., Rastogi, V., Satpute, P., & Sharma, V. (2015). Tumour angiogenesis and angiogenic inhibitors: A review. Journal of Clinical and Diagnostic Research, 9(6), XE01.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Indian Journal of Veterinary Sciences & Biotechnology
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
How to Cite
